Почетна › Беркитов лимфом › Северна Каролина
Клинички испитувања за Беркитов лимфом во Северна Каролина
13 студии за Беркитов лимфом бараат учесници на локации во Северна Каролина.
Градови во Северна Каролина
Официјален текст на студијата (англиски)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- и уште 2
Се регрутираФаза 2
366 Days – 46 Years · Сите полови · Ажурирано 2.10.2026 · NCT06124157Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- East Carolina University, Greenville
- Wake Forest University Health Sciences, Winston-Salem
Се регрутираФаза 3
Возраст од 18 до 39 · Сите полови · Ажурирано 2.10.2026 · NCT03150693Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Wake Forest University Health Sciences, Winston-Salem
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT03739814Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
- и уште 2
Се регрутираФаза 2
365 Days · Сите полови · Ажурирано 25.9.2026 · NCT06317662Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Duke University, Durham
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT07648264A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- и уште 3
Се регрутираФаза 2
Возраст од 1 до 30 · Сите полови · Ажурирано 1.9.2026 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- и уште 4
Се регрутираФаза 3
365 Days – 25 Years · Сите полови · Ажурирано 25.8.2026 · NCT03959085Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Levine Children's Hospital, Charlotte
Се регрутираФаза 2
Возраст од 7 до 25 · Сите полови · Ажурирано 19.8.2026 · NCT05082519Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill
Се регрутираФаза 1/2
Возраст од 13 до 90 · Сите полови · Ажурирано 6.8.2026 · NCT06533579Registry of Older Patients With Cancer
- Seby B. Jones Cancer Center, Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
- East Carolina University, Greenville
- и уште 4
Се регрутираНабљудувачка студија
Возраст 65 и постари · Сите полови · Ажурирано 29.6.2026 · NCT01137825Study of SGR-1505 in Mature B-Cell Neoplasms
- Duke University, Durham
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 13.2.2026 · NCT05544019Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
Се регрутираНабљудувачка студија
Возраст од 18 до 120 · Сите полови · Ажурирано 27.10.2025 · NCT01137643The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- Atrium Health - Levine Cancer Center, Charlotte
Се регрутираФаза 2
Возраст од 1 до 25 · Сите полови · Ажурирано 4.5.2025 · NCT03509961Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.